Status:
UNKNOWN
Searching for the Liver Cancer-Related Biomarkers
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18-90 years
Brief Summary
Hepatocellular carcinoma (HCC) has been the leading cause of cancer death in Taiwan. About 6000-8000 people died of this cancer every year in Taiwan. Though regular sonographic examination can early d...
Detailed Description
Cell lines Hep3B and Huh7 HCC cell lines will be cultured in (Dulbecco's modified Eagle medium) DMEM containing 10% fetal calf serum and incubated at 37 C in 5% CO2 incubator. The rationale of using H...
Eligibility Criteria
Inclusion
- hepatocellular carcinoma
Exclusion
- multiple cancers
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00154544
Start Date
August 1 2004
Last Update
December 20 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100